The Cystic Fibrosis-Like Airway Surface Layer Is not a Significant Barrier for Delivery of Eluforsen to Airway Epithelial Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Cystic Fibrosis-Like Airway Surface Layer Is not a Significant Barrier for Delivery of Eluforsen to Airway Epithelial Cells

Published:2019-10-01 Issue:5 Volume:32 Page:303-316
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Brinks Vera¹,Lipinska Katarzyna¹,de Jager Miranda¹,Beumer Wouter¹,Button Brian²³,Livraghi-Butrico Alessandra³,Henig Noreen¹,Matthee Bianca¹

Affiliation:

1. ProQR Therapeutics, Leiden, The Netherlands.

2. Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

3. Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2018.1502

Reference38 articles.

1. A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease

2. Role of CFTR in Airway Disease

3. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

4. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic deletion of symmetricalCFTRexons reveals new therapeutic targets for exon skipping antisense oligonucleotides;2024-08-29

2. Cystic fibrosis management in pediatric population—from clinical features to personalized therapy;Frontiers in Pediatrics;2024-05-10

3. Cystic Fibrosis Modulator Therapies: Bridging Insights from CF to other Membrane Protein Misfolding Diseases;Israel Journal of Chemistry;2024-01-24

4. Gene therapy for Cystic Fibrosis: recent advances and future prospects;Acta Naturae;2023-08-03

5. Lack of association between leptin concentrations and cystic fibrosis: A meta-analysis and regression;Frontiers in Endocrinology;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3